Evidence map›Paper›PMID 31240898›Full record

ArticleJournal of biomedical optics2019

Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging.

Antonia Lichtenegger, Johanna Gesperger, Barbara Kiesel, Martina Muck, Pablo Eugui, Danielle J Harper, Matthias Salas, Marco Augustin, Conrad W Merkle, Christoph K Hitzenberger and 3 more

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Antonia LichteneggerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Johanna GespergerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Barbara KieselGeneral Hospital and Medical University of Vienna, Univ. Klinik Neurochirurgie, Vienna, Austria.
Martina MuckMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Pablo EuguiMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Danielle J HarperMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Matthias SalasMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Marco AugustinMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Conrad W MerkleMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Christoph K HitzenbergerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Georg WidhalmGeneral Hospital and Medical University of Vienna, Univ. Klinik Neurochirurgie, Vienna, Austria.
Adelheid WoehrerGeneral Hospital and Medical University of Vienna, Institute of Neurology, Vienna, Austria.
Bernhard BaumannMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a multimodal visible light optical coherence microscopy (OCM) and fluorescence imaging (FI) setup. Specification and phantom measurements were performed to characterize the system. Two applications in neuroimaging were investigated. First, curcumin-stained brain slices of a mouse model of Alzheimer's disease were examined. Amyloid-beta plaques were identified based on the fluorescence of curcumin, and coregistered morphological images of the brain tissue were provided by the OCM channel. Second, human brain tumor biopsies retrieved intraoperatively were imaged prior to conventional neuropathologic work-up. OCM revealed the three-dimensional structure of the brain parenchyma, and FI added the tumor tissue-specific contrast. Attenuation coefficients computed from the OCM data and the florescence intensity values were analyzed and showed a statistically significant difference for 5-aminolevulinic acid (5-ALA)-positive and -negative brain tissues. OCM findings correlated well with malignant hot spots within brain tumor biopsies upon histopathology. The combination of OCM and FI seems to be a promising optical imaging modality providing complementary contrast for applications in the field of neuroimaging.

Indexed as

Alzheimer DiseaseAnimalsBrainBrain NeoplasmsHumansImage Processing, Computer-AssistedMiceMicroscopyNeuroimagingOptical ImagingPlaque, AmyloidTomography, Optical Coherence5-aminolevulinic acidAlzheimer’s diseasegliomaoptical coherence tomographyprotoporphyrin IXsupercontinuum laser

Identifiers

PMID31240898
PMCPMC6977170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.